Login

Dr. Pitor Kopinski - Residency at Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Residents describe their training experience at Mayo Clinic's Department of Ophthalmology.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Financial First Steps for Divorce with CDFA Melissa Ellis | Melissa Ellis - Founder, Sapphire Wealth Planning
00:10:00
An analyst discusses Naver and SK Telecom and their strategies.
00:10:00
Ascendant Resources' Mark Brennan on Feasibility Study and Project Funding Challenges
00:10:00
Unlocking Wealth Potential: The Strategic Advantage of Roth Conversions by Raquel Hinman | Raquel Hinman - Founder & Principal of Hinman Financial Planning, Inc.
00:10:00
Emerald Resources MD Morgan Hart Presents Progress on Okvau Gold Project
00:10:00
Vecima Networks Inc. - Careers wins the Innovation Award at the 2018 Greater Victoria Business Awards.
00:10:00
Seeing the potential in Box CEO Aaron Levie|Mamoon Hamid,Partner, Kleiner Perkins
00:10:00
Sabina Gold & Silver Corp. CEO Bruce McLeod outlines the company's goal to become Canada's next intermediate gold producer and highlights progress on pre-development civil works at the Back River Gold Project.|Bruce McLeod CEO of Sabina Gold & Silver Cor
00:00:00
RedX Pharma drug candidate pipeline underpins strong first half progress - Lisa Anson Chief Executive Officer, Redx Pharma
00:00:00
Karin Fischer, CEO, RLS Global
00:10:00
CEO Perspectives: Navigating Fiscal Policy, Market Volatility, and Economic Growth | John Koudounis, CEO , Calamos Investments LLC.
00:10:00
Amica SA: 2022 Summary Conference Recording with Jacek Rutkowski | Jacek Rutkowski, President , Amica SA.

© 2017 - Neuhu+